BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2001
View Archived Issues
Abgenix reports 2000 highlights and goals for 2001
Read More
OP-1 receives positive and negative opinions from regulatory authorities
Read More
ExonHit Therapeutics expands operations and scope
Read More
Peptide Therapeutics consolidates operations and changes name
Read More
MTC-DOX assigned orphan drug status for liver cancer Rx by FDA
Read More
PK/PD modeling following single oral doses of NN-703
Read More
CytRx and University of Cincinnati to investigate CRL-5861 for muscular dystrophy
Read More
NIAID grant awarded to Aphios for development of HIV vaccine adjuvant
Read More
Newly discovered protein may have major impact on bacterial resistance
Read More
Testosterone progressive hydration buccal tablets show promise in phase III
Read More
Preparation and antitumor activity of new xanthone compound from Asta Medica
Read More
Abbott's new ketolide derivatives display potent and broad-spectrum antibacterial activity
Read More
Two new series of vitronectin receptor antagonists particularly useful in osteoporosis
Read More
Femara receives E.U. approval as first-line breast cancer therapy
Read More
COX-2 inhibitors as antiinflammatory, analgesic agents presented by Pfizer
Read More
New matrix metalloproteinase inhibitors show potential in arthritis
Read More
Patent assigned to Warner-Lambert covers MMP inhibitors for various disorders
Read More
New peptoid MMP inhibitors useful for cancer, etc.
Read More
Arena and Taisho expand obesity orphan receptor research agreement
Read More
FTC consent decree relating to GSK merger finalized
Read More
Pherin cleared to begin clinical trials of antianxiety compound
Read More
Neuron Therapeutics begins phase I trial with novel stroke therapy
Read More
Trisenox moves into multiple myeloma clinical trials
Read More
Oral sodium tungstate reduces hyperglycemia and hypertriglyceridemia in ZDF rats
Read More
Novogen phase I trial of anticancer drug phenoxodiol approved by FDA
Read More
CroFab now available in the U.S. for treatment of poisonous snakebites
Read More
Sedecim Therapeutics: a new company focusing on IL-16-related therapies
Read More